Post Authorization
FDA: Independent committee recommends authorization of coronavirus vaccine
An independent committee of experts recommended Thursday that the Food and Drug Administration authorize the Pfizer and BioNTech COVID-19 vaccine for people over the age of 16. Now, the FDA will decide whether to follow that recommendation. The agency could announce a decision within days. If they do authorize the vaccine, health care workers could begin receiving the shots almost immediately. The Vaccines and Related Biological Products Advisory Committee (VRBPAC) met all day to review data on the vaccine, discuss plans for distribution, and outline plans for continued research. FDA scientists published a report about the vaccine on Tuesday, which analyzed data from the pharmaceutical companies and found that the vaccine was safe and 95 percent at preventing symptomatic COVID-19. Data fro...
